Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach.

ABSTRACT:

Objective

We suggested cervical cancer screening strategies for women living with HIV (WLHIV) by comparing their precancer risks to general population women, and then compared our suggestions with current Centers for Disease Control and Prevention (CDC) guidelines.

Design

We compared risks of biopsy-confirmed cervical high-grade squamous intraepithelial neoplasia or worse (bHSIL+), calculated among WLHIV in the Women's Interagency HIV Study, to 'risk benchmarks' for specific management strategies in the general population.

Methods

We applied parametric survival models among 2423 WLHIV with negative or atypical squamous cell of undetermined significance (ASC-US) cytology during 2000-2015. Separately, we synthesized published general population bHSIL+ risks to generate

SUBMITTER: Robbins HA 

PROVIDER: S-EPMC5531443 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature